Showing posts with label visceral fat. Show all posts
Showing posts with label visceral fat. Show all posts

Wednesday, June 9, 2010

Cortisol, stress, excessive gluconeogenesis, and visceral fat accumulation

Cortisol is a hormone that plays several very important roles in the human body. Many of these are health-promoting, under the right circumstances. Others can be disease-promoting, especially if cortisol levels are chronically elevated.

Among the disease-promoting effects of chronically elevated blood cortisol levels are that of excessive gluconeogenesis, causing high blood glucose levels even while a person is fasting. This also causes muscle wasting, as muscle tissue is used to elevate blood glucose levels.

Cortisol also seems to transfer body fat from subcutaneous to visceral areas. Presumably cortisol promotes visceral fat accumulation to facilitate the mobilization of that fat in stressful “fight-or-flight” situations. Visceral fat is much easier to mobilize than subcutaneous fat, because visceral fat deposits are located in areas where vascularization is higher, and are closer to the portal vein.

The problem is that modern humans often experience stress without the violent muscle contractions of a “fight-or-flight” response that would have normally occurred among our hominid ancestors. Arguably those muscle contractions would have normally been in the anaerobic range (like a weight training set) and be fueled by both glycogen and fat. Recovery from those anaerobic "workouts" would induce aerobic metabolic responses, for which the main fuel would be fat.

Coates and Herbert (2008) studied hormonal responses of a group of London traders. Among other interesting results, they found that a trader’s blood cortisol level rises with the volatility of the market. The figure below (click to enlarge) shows the variation in cortisol levels against a measure of market volatility.


On a day of high volatility cortisol levels can be significantly higher than those on a day with little volatility. The correlation between cortisol levels and market volatility in this study was a very high 0.93. This is almost a perfectly linear association. Market volatility is associated with traders’ stress levels; stress that is experienced without heavy physical exertion.

Cortisol levels go up a lot with stress. And modern humans live in hyper-stressful environments. Unfortunately stress in modern urban environments is often experienced while sitting down. In the majority of cases stress is experienced without any vigorous physical activity in response to it.

As Geoffrey Miller pointed out in his superb book, The Mating Mind, the lives of our Paleolithic ancestors would probably look rather boring to a modern human. But that is the context in which our endocrine responses evolved.

Our insatiable appetite for over stimulation may be seen as a disease. A modern disease. A disease of civilization.

Well, it is no wonder that heavy physical activity is NOT a major trigger of death by sudden cardiac arrest. Bottled up modern human stress likely is.

We need to learn how to make stress management techniques work for us.

Visiting New Zealand at least once and watching this YouTube video clip often to remind you of the experience does not hurt either! Note the “honesty box” at around 50 seconds into the clip.

References:

Coates, J.M., & Herbert, J. (2008). Endogenous steroids and financial risk taking on a London trading floor. Proceedings of the National Academic of Sciences of the U.S.A., 105(16), 6167–6172.

Elliott, W.H., & Elliott, D.C. (2009). Biochemistry and molecular biology. 4th Edition. New York: NY: Oxford University Press.

Tuesday, May 18, 2010

Cheese consumption, visceral fat, and adiponectin levels

Several bacteria feed on lactose, the sugar found in milk, producing cheese for us as a byproduct of their feeding. This is why traditionally made cheese can be eaten by those who are lactose intolerant. Cheese consumption predates written history. This of course does not refer to processed cheese, frequently sold under the name “American cheese”. Technically speaking, processed cheese is not “real” cheese.

One reasonably reliable way of differentiating between traditional and processed cheese varieties is to look for holes. Cheese-making bacteria produce a gas, carbon dioxide, which leaves holes in cheese. There are exceptions though, and sometimes the holes are very small, giving the impression of no holes. Another good way is to look at the label and the price; usually processed cheese is labeled as such, and is cheaper than traditionally made cheese.

Cheese does not normally spoil; it ages. When vacuum-wrapped, cheese is essentially in “suspended animation”. After opening it, it is a good idea to store it in such a way as to allow it to “breathe”, or continue aging. Wax paper does a fine job at that. This property, extended aging, has made cheese a very useful source of nutrition for travelers in ancient times. It was reportedly consumed in large quantities by Roman soldiers.

Walther and colleagues (2008) provide a good review of the role of cheese in nutrition and health. The full reference is at the end of this post. They point out empirical evidence that cheese, particularly that produced with Lactobacillus helveticus (e.g., Gouda and Swiss cheese), contributes to lowering blood pressure, stimulates growth and development of lean body tissues (e.g., muscle), and has anti-carcinogenic properties.

The health-promoting effects of cheese were also reviewed by Higurashi and colleagues (2007), who hypothesized that those effects may be in part due to the intermediate positive effects of cheese on adiponectin and visceral body fat levels. They conducted a study with rats that supports those hypotheses.

In the study, they fed two groups of rats an isocaloric diet with 20 percent of fat, 20 percent of protein, and 60 percent of carbohydrate (in the form of sucrose). In one group, the treatment group, Gouda cheese (produced with Lactobacillus helveticus) was the main source of protein. In the other group, the control group, isolated casein was the main source of protein. The researchers were careful to avoid confounding variables; e.g., they adjusted the vitamin and mineral intake in the groups so as to match them.

The table below (click to enlarge) shows initial and final body weight, liver weight, and abdominal fat for both groups of rats. As you can see, the rats more than quadrupled in weight by the end of the 8-weight experiment! Abdominal fat was lower in the cheese group; one type of visceral fat, mesenteric, was significantly lower. Whole body weight-adjusted liver weight was higher in the cheese group. Liver weight increase is often associated with increased muscle mass. The rats in the cheese group were a little heavier on average, even though they had less abdominal fat.


The figure below shows adiponectin levels at the 4-week and 8-week marks. While adiponectin levels decreased in both groups, which was to be expected given the massive gain in weight (and probably body fat mass), only in the casein group the decrease in adiponectin was significant. In fact, the relatively small decrease in the cheese group is a bit surprising given the increase in weight observed.


If we could extrapolate these findings to humans, and this is a big “if”, one could argue that cheese has some significant health-promoting effects. There is one small problem with this study though. To ensure that the rats consumed the same number of calories, the rats in the casein group were fed slightly more sucrose. The difference was very small though; arguably not enough to explain the final outcomes.

This study is interesting because the main protein in cheese is actually casein, and also because casein powders are often favored by those wanting to put on muscle as part of a weight training program. This study suggests that the cheese-ripening process induced by Lactobacillus helveticus may yield compounds that are particularly health-promoting in three main ways – maintaining adiponectin levels; possibly increasing muscle mass; and reducing visceral fat gain, even in the presence of significant weight gain. In humans, reduced circulating adiponectin and increased visceral fat are strongly associated with the metabolic syndrome.

One caveat: if you think that eating cheese may help wipe out that stubborn abdominal fat, think again. This is a topic for another post. But, briefly, this study suggests that cheese consumption may help reduce visceral fat. Visceral fat, however, is generally fairly easy to mobilize (i.e., burn); much easier than the stubborn subcutaneous body fat that accumulates in the lower abdomen of middle-aged men and women. In middle-aged women, stubborn subcutaneous fat also accumulates in the hips and thighs.

Could eating Gouda cheese, together with other interventions (e.g., exercise), become a new weapon against the metabolic syndrome?

References:

Higurashi, S., Kunieda, Y., Matsuyama, H., & Kawakami, H. (2007). Effect of cheese consumption on the accumulation of abdominal adipose and decrease in serum adiponectin levels in rats fed a calorie dense diet. International Dairy Journal, 17(10), 1224–1231.

Walther, B., Schmid, A., Sieber, R., & Wehrmüller, K. (2008). Cheese in nutrition and health. Dairy Science Technology, 88(4), 389-405.